ACADIA PHARMACEUTICALS INC's ticker is and the CUSIP is 004225908. A total of 6 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $994,762 | +11.5% | 53,800 | +88.8% | 0.00% | – |
| Q4 2023 | $892,335 | -10.4% | 28,500 | -40.4% | 0.00% | – |
| Q3 2023 | $996,152 | +28.2% | 47,800 | +15.7% | 0.00% | – |
| Q1 2023 | $777,266 | +11.5% | 41,300 | -5.7% | 0.00% | – |
| Q4 2022 | $697,296 | +31.6% | 43,800 | +35.2% | 0.00% | – |
| Q3 2022 | $530,000 | -63.3% | 32,400 | -68.4% | 0.00% | -100.0% |
| Q2 2022 | $1,446,000 | – | 102,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 154,500 | $3,825,000 | 0.00% |